🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Targeting apoptosis in cancer therapy

Benedito A. Carneiro, Wafik S. El-Deiry (2020)

Nature Reviews Clinical Oncology

2.3K citesjournal articlePDF

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

T.A. Chan, M. Yarchoan et al. (2019)

Annals of Oncology

2.3K citesjournal articlePDF

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

Tsukasa Shibue, Robert A. Weinberg (2017)

Nature Reviews Clinical Oncology

2.3K citesjournal articlePDF

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

Melody A. Cobleigh, Charles L. Vogel et al. (1999)

Journal of Clinical Oncology

2.2K citesjournal articlePDF

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Soonmyung Paik, Gong Tang et al. (2006)

Journal of Clinical Oncology

2.2K citesjournal articlePDF

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

Aurélien Marabelle, Marwan Fakih et al. (2020)

The Lancet Oncology

2.4K citesjournal articlePDF

Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma

Robert J. Motzer, Jennifer Bacik et al. (2002)

Journal of Clinical Oncology

2.2K citesjournal articlePDF

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

Joel Shapiro, J Jan B van Lanschot et al. (2015)

The Lancet Oncology

2.2K citesjournal articlePDF

The Global Burden of Cancer 2013

Christina Fitzmaurice, Daniel Dicker et al. (2015)

JAMA Oncology

2.1K citesjournal articlePDF

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

A TROTTI, A COLEVAS et al. (2003)

Seminars in Radiation Oncology

2.2K citesjournal articlePDF

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

Nancy Lee Harris, Elaine S. Jaffe et al. (1999)

Journal of Clinical Oncology

2.1K citesjournal articlePDF

Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials

Laurie Gaspar, Charles Scott et al. (1997)

International Journal of Radiation Oncology*Biology*Physics

2.1K citesjournal articlePDF

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

Andrew X Zhu, Richard S Finn et al. (2018)

The Lancet Oncology

2.1K citesjournal articlePDF

CTLA-4 and PD-1 Pathways

Elizabeth I. Buchbinder, Anupam Desai (2016)

American Journal of Clinical Oncology

2.2K citesjournal articlePDF

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Jean-Pierre Pignon, Hélène Tribodet et al. (2008)

Journal of Clinical Oncology

2.2K citesjournal articlePDF